Table 3.
Influence of NE challenge on intestinal barrier function and modulation effects by probiotics.
| S/N | Response to NE Challenge | Probiotic Strain | Response to Dietary Probiotics | Ref |
|---|---|---|---|---|
| 1 | Decreased the expression of CLDN-1, CLDN-3, ZO-1 and ZO-2 | B. licheniformis H2 | Increased the expression of these proteins | [12] |
| 2 | Reduced the expression of IGF-1 and EGF in the gut | Multi probiotic strain. B. subtilis | Increased IGF-1 and EGF in the jejunum and ileum | [18] |
| 3 | Increased expression of CLDN3, | Multi strain | Decreased CLDN3; increased CLDN3 and Muc-2 on day 42 | [19] |
| 4 | Reduced the expression of CLDN-3 | B. licheniformis | Increased the expression of CLDN-3 | [23] |
| 5 | Reduced mRNA expression of Muc2; reduced IAP activity | B. coagulans | No effect on mucin expression; increased IAP activity in the jejunum | [25] |
| 6 | Decreased CLDN-1 but had no influence on OCLDN and CLDN-2 | L. fermentum, B. coagulans | Increased CLDN-3 | [26] |
| 7 | Reduced mRNA expression of CLDN-3, CLDN-1 and ZO-2 | Primlac: multi strain probiotics | Increased expression of these proteins | [94] |
| 8 | Reduced expression of CLDN-1 and OCLDN transcripts; increased Muc-2 | B. subtilis DSM29784 | No effect on expression of claudins | [95] |
| 9 | Increased level of serum DAO and reduced CLDN-3 and MUC-2 | B. amyloliquefaciens BLCC1-0238 | Reduced level of serum DAO and D-lactic acid; increased OCLN, ZO-1 and MUC2 | [110] |
| 10 | Reduced CLDN-3 and ZO-1; increased MLCK mRNA expression | E. faecium | Increased expression of CLDN-1 | [112] |
| 11 | Reduced JAM2 | B. licheniformis | Increased JAM2 | [122] |